Bank of America related stories
All articles and analysis
TPG to pay $1.3bn for Canadian drug firm(3)Axcan Pharma has agreed to be taken private by TPG in a transaction valued at $1.3 billion. It’s the firm’s third healthcare acquisition this year.
- Conversus commits $70m to TPG and TowerBrook funds
Despite further gains in its portfolio’s value the fund of funds' discount to NAV is increasing as listed private equity firms continue to suffer.
- Financial services M&A veteran joins Carlyle
UBS investment banker Olivier Sarkozy has joined The Carlyle Group’s recently formed financial services team. The team aims to exploit low valuations in the financial services sector, which has been hit by recent worldwide credit market problems.
- Pantheon hires Chicago partner(4)
Pantheon Ventures has made a second senior management hire in a US regional office in three months as the firm diversifies away from San Francisco.
- TPG to pay $1.3bn for Canadian drug firm(2)
Axcan Pharma has agreed to be taken private by TPG in a transaction valued at $1.3 billion. It’s the firm’s third healthcare acquisition this year.
- Private exchanges to consolidate(4)
NASDAQ is consolidating Goldman Sachs' GSTrUE, Bear Stearns’ Best Markets, and OPUS-5, all private exchanges, which allow private equity firms to list with less disclosure requirements.
- Private exchanges to consolidate(3)
NASDAQ is consolidating Goldman Sachs' GSTrUE, Bear Stearns’ Best Markets, and OPUS-5, all private exchanges, which allow private equity firms to list with less disclosure requirements.
- Private exchanges to consolidate(2)
NASDAQ is consolidating Goldman Sachs' GSTrUE, Bear Stearns’ Best Markets, and OPUS-5, all private exchanges, which allow private equity firms to list with less disclosure requirements.
- Pantheon hires Chicago partner(3)
Pantheon Ventures has made a second senior management hire in a US regional office in three months as the firm diversifies away from San Francisco.
- Cerberus axes $6.6bn United Rentals buyout(4)
Cerberus is joining KKR, Goldman Sachs and JC Flowers to become the latest buyout firm to walk away from a megadeal agreed before the liquidity crisis.